Knihobot
Miláček čtenářů je právě vyprodaný
Máte ji v knihovně?Získejte od 25 Kč do 37 Kč prodejem této knihy.
Prodat knihy

Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer

An Update

Parametry

  • 290 stránek
  • 11 hodin čtení

Více o knize

This is an advanced reference and clinical text documenting the latest advances and current knowledge on all aspects of diagnosing and treating renal, bladder and prostate cancer. It contains 33 original, new chapters by high-level experts in urology, oncology, endocrinology, immunohematology, and pathology from leading medical centers in the United States and Europe. Their contributions provide essential updates on today's most intensely researched and debated issues in renal, bladder and prostate cancer. These include molecular genetics, organ-sparing surgery, tumor nephrectomy, metastatic renal cell carcinoma, gene therapy, optimal strategies for early detection, accuracy of grading, avoiding aggressive treatment when unneeded, advances in radiotherapy, minimal invasive treatment alternatives, endocrine treatment, androgen monotherapy, quality of life issues, new approaches to drug development, intravesical chemotherapy, adjuvant therapy, urinary cytokines as predictors, bladder preservation, orthotopic urinary diversion, systemic treatment, and contemporary approaches for chemotherapy. Massively referenced and fully indexed.

Nákup knihy

Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer, Fritz H. Schröder, Gerald H. Mickisch, Karl H. Kurth

Jazyk
Rok vydání
1999
Vazba
(pevná)
Jakmile se objeví, pošleme e-mail.

Doručení

Platební metody

Nikdo zatím neohodnotil.

Titul
Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer
Podtitul
An Update
Jazyk
anglicky
Rok vydání
1999
Vazba
pevná
Počet stran
290
ISBN10
1850700818
ISBN13
9781850700814
Série
Anotace
This is an advanced reference and clinical text documenting the latest advances and current knowledge on all aspects of diagnosing and treating renal, bladder and prostate cancer. It contains 33 original, new chapters by high-level experts in urology, oncology, endocrinology, immunohematology, and pathology from leading medical centers in the United States and Europe. Their contributions provide essential updates on today's most intensely researched and debated issues in renal, bladder and prostate cancer. These include molecular genetics, organ-sparing surgery, tumor nephrectomy, metastatic renal cell carcinoma, gene therapy, optimal strategies for early detection, accuracy of grading, avoiding aggressive treatment when unneeded, advances in radiotherapy, minimal invasive treatment alternatives, endocrine treatment, androgen monotherapy, quality of life issues, new approaches to drug development, intravesical chemotherapy, adjuvant therapy, urinary cytokines as predictors, bladder preservation, orthotopic urinary diversion, systemic treatment, and contemporary approaches for chemotherapy. Massively referenced and fully indexed.